CRISPR/Cas9 genome editing to treat sickle cell disease
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Hoofdauteur: | Ullah, Mohammad |
---|---|
Andere auteurs: | Islam, Farzana |
Formaat: | Thesis |
Taal: | English |
Gepubliceerd in: |
Brac University
2023
|
Onderwerpen: | |
Online toegang: | http://hdl.handle.net/10361/19355 |
Gelijkaardige items
-
CRISPR/Cas9 system: A versatile gene editing tool in disease prevention and treatment
door: Maria, Amatul
Gepubliceerd in: (2020) -
Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
door: Shaikat, Mahdi Mubin
Gepubliceerd in: (2023) -
A review on CRISPR-Cas system based applications in Oncology
door: Sadia, Mir
Gepubliceerd in: (2022) -
A review on CRISPR Technology as an Antiviral Tool
door: Srishti, Sanjida Ahmed
Gepubliceerd in: (2023) -
CRISPR: a revolutionary tool for modeling and treating cancer and Duchenne muscular dystrophy
door: Eva, Israt Ara Jannat
Gepubliceerd in: (2023)